Key Insights

Highlights

Success Rate

81% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

12.1%

4 terminated out of 33 trials

Success Rate

81.0%

-5.6% vs benchmark

Late-Stage Pipeline

9%

3 trials in Phase 3/4

Results Transparency

24%

4 of 17 completed with results

Key Signals

4 with results81% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (12)
P 1 (2)
P 2 (6)
P 3 (1)
P 4 (2)

Trial Status

Completed17
Terminated4
Recruiting4
Active Not Recruiting3
Not Yet Recruiting2
Enrolling By Invitation2

Trial Success Rate

81.0%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (33)

Showing 20 of 20 trials
NCT00923221Recruiting

Collection of Blood From Patients With Prostate Cancer

NCT06192758Not ApplicableActive Not RecruitingPrimary

Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device

NCT07220720Phase 2RecruitingPrimary

POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions

NCT07424547Phase 1Recruiting

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

NCT03197896Not ApplicableCompletedPrimary

Educational Intervention in Increasing Knowledge About Prostate Cancer in High-Risk Neighborhoods

NCT07327424Not ApplicableActive Not RecruitingPrimary

Feasibility of Suprapubic Transvesical Endoscopic Prostatectomy

NCT07305142Not ApplicableCompleted

Comparison of the Integrated Posterior-Anterior-Lateral Approach and the Posterior Approach in Robotic Radical Prostatectomy

NCT07296510CompletedPrimary

Is it Feasible to Use Data Obtained Through a Three-Dimensional Reconstructed Image to Assist in Prostate Targeted Biopsy?

NCT07164638Not ApplicableEnrolling By Invitation

Lung Ultrasound Versus Inferior Vena Cava Collapsibility Index for Early Prediction of Volume Overload During Transurethral Resection of Prostate

NCT01078662Phase 2Completed

Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats

NCT06364865Enrolling By Invitation

AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study

NCT03047135Phase 2Active Not RecruitingPrimary

Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis

NCT07020364RecruitingPrimary

Feasibility and Safety of a Single Working Element for Bipolar and Laser Enucleation in Prostate Surgery: A Prospective Study

NCT04518072TerminatedPrimary

Synthetic Metabolic and Genetic Networks for Medical Diagnosics

NCT06901115Not ApplicableCompleted

Corkscrew Technique: A Novel Modification in Transurethral Resection of Large Prostate (60-100 g) Optimizing Resection Efficacy and Safety: A Double-blind Randomized Controlled Trial

NCT03318367Not ApplicableTerminatedPrimary

Virtual Reality Education Module in Reducing Anxiety and Increasing Knowledge in Patients With Prostate Cancer Undergoing Radiation Therapy

NCT03197948TerminatedPrimary

Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing Treatment

NCT06605846Not ApplicableCompletedPrimary

Otago Exercises on the Risk of Falling in Prostatic Cancer Patients Receiving Androgen Deprivation Therapy

NCT06789744Not ApplicableNot Yet Recruiting

Enhanced Recovery After Urologic Surgery

NCT06772116Not Yet RecruitingPrimary

Focal Therapy in Localized Prostate Cancer: a Prospective Registry

Scroll to load more

Research Network

Activity Timeline